Authors
Jing-Yi Chen, Yu-Cheng Ho, Yu-Ning Teng
Published in
Drug development research. Volume 87. Issue 8.
Abstract
Multidrug resistance (MDR) significantly hampers effective cancer treatment, particularly in hepatocellular carcinoma (HCC). Natural compounds, such as Raddeanin A (RA), have shown promise in reversing MDR. This study investigates the efficacy and mechanisms by which RA overcomes MDR in HCC cells. The human hepatocellular carcinoma cell line HepG2 and its multidrug-resistant variant, HepG2/VIN, were used. Cytotoxicity assays, membrane fluidity assessments, and evaluations of ATP-binding cassette (ABC) transporter activity were conducted to elucidate the mechanisms of RA. Additionally, the production of reactive oxygen species (ROS) and the induction of apoptosis were analyzed. RA effectively reversed resistance to chemotherapeutic agents, significantly reducing their IC50 values in HepG2/VIN cells. Mechanistically, RA enhanced membrane fluidity and downregulated P-glycoprotein (P-gp) expression, inhibiting its efflux function. RA also induced ROS production, leading to mitochondrial dysfunction and apoptosis. Notably, RA exhibited uncompetitive inhibition of doxorubicin efflux, indicating a novel interaction with P-gp. RA employs a dual mechanism to combat MDR in HCC by modulating membrane fluidity and inducing apoptosis via ROS generation. These findings suggest that RA could serve as a potential therapeutic agent in overcoming MDR, warranting further investigation in clinical settings.
PMID:
43049239
Bibliographic data and abstract were imported from PubMed on 18 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 7
- Comments 0